The approval of a first-of-its kind cancer therapy creates new challenges related to safety, access, and costs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1377/hlthaff.2017.1032 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!